-
Sharing Knowledge, Building Community
The executive editor of Cancer Today previews the new issue.
by Kevin McLaughlin
-
Young Colorectal Cancer Patients Are Often Misdiagnosed
A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
by Bradley Jones
-
2018 SABCS: Choosing the Right Treatment
Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
by Kate Yandell
-
Reinforcements for Cancer Research
Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
-
Does Medicaid Expansion Have an Impact?
Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
by Marci A. Landsmann
-
Achieving Health Equality
National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
by Marci A. Landsmann
-
The Ins and Outs of Tumor Testing
In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
-
The Many Faces of Patient Advocacy
Advocates shared their stories and projects at the AACR Annual Meeting.
by Kate Yandell
-
A Response to Roadblocks
The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
-
Focusing on the Fundamentals
National Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency.
by Marci A. Landsmann
Cancer Talk
Delaying Treatment Resistance
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona